Rheumatoid arthritis: Update on the newest DMARDs and their potential place in therapy

Rheumatoid arthritis: Update on the newest DMARDs and their potential place in therapy

In the last four years, four new disease modifying antirheumatic drugs have become available. Schrand discusses how the drugs are dramatically changing the treatment of rheumatoid arthritis.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Formulary (Cleveland, Ohio) Ohio), 2002-06, Vol.37 (6), p.301
Hauptverfasser: Schrand, Linda M, Tuetken, Rebecca
Format: Artikel
Sprache:eng
Schlagworte:
Arthritis
Clinical trials
Cytokines
Drug dosages
Drug therapy
FDA approval
Immunosuppressive agents
Nonsteroidal anti-inflammatory drugs
Patients
Pharmaceutical research
Prescription drugs
Rheumatoid arthritis
Tumor necrosis factor-TNF
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In the last four years, four new disease modifying antirheumatic drugs have become available. Schrand discusses how the drugs are dramatically changing the treatment of rheumatoid arthritis.
ISSN:1082-801X
1938-1166